Bevacizumab plus irinotecan therapy in relapsed, heavily pre-treated malignant glioma: A case series

被引：0
|
作者：
Friedland, D. M. [1 ]
Ali, S. A. [1 ]
Ahmad, A. [1 ]
Rahman, M. [1 ]
Bejjani, G. [1 ]
Braffet, M. [1 ]
机构：
[1] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
12500
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Topoisomerase inhibitors: Combination of irinotecan and epirubicin is feasible as salvage therapy for heavily pre-treated advanced lung cancer patients
    Malik, S
    Min, F
    Hwang, J
    Marshall, J
    LUNG CANCER, 2005, 49 : S257 - S257
  • [22] A heavily pre-treated adenocarcinoma patient with EGFR exon 20 insertion mutation responded to pembrolizumab plus nab-paclitaxel/bevacizumab: a case report
    Huang, Xiaojie
    Yang, Yan
    Wang, Pingli
    Han-Zhang, Han
    Ding, Liren
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (06) : 6997 - 7002
  • [23] Combination of paclitaxel and bevacizumab in heavily pre-treated non-small-cell lung cancer (NSCLC) patients: a case series study on 15 Patients
    Le Moulec, Sylvestre
    Hadoux, Julien
    Gontier, Eric
    Chargari, Cyrus
    Helissey, Carole
    Lamand, Virginie
    Tanz, Rachid
    Farace, Francoise
    Vedrine, Lionel
    Bonardel, Gerald
    Soria, Jean-Charles
    Besse, Benjamin
    BULLETIN DU CANCER, 2013, 100 (12) : E30 - E37
  • [24] Oral etoposide in heavily pre-treated metastatic breast cancer: A retrospective series
    Giannone, G.
    Milani, A.
    Ghisoni, E.
    Genta, S.
    Mittica, G.
    Montemurro, F.
    Valabrega, G.
    BREAST, 2018, 38 : 160 - 164
  • [25] Contemporary Use of VTD-PACE As Bridge Therapy in Patients with Heavily Pre-Treated Relapsed/Refractory Multiple Myeloma
    Kurish, Heena P.
    Row, Kerri
    Kurkowski, Austin
    Rice, Mikhaila
    Rudoni, Joslyn
    Khouri, Jack
    Mazzoni, Sandra
    Samaras, Christy J.
    Williams, Louis S.
    van Heeckeren, Willem
    Valent, Jason
    Anwer, Faiz
    BLOOD, 2022, 140 : 12496 - 12497
  • [26] Risk of Adverse Vascular Events in Patients with Malignant Glioma Treated with Bevacizumab Plus Irinotecan: A Systematic Review and Meta-Analysis
    Dong, Jiawei
    Meng, Xiangqi
    Li, Siyi
    Chen, Qun
    Shi, Lei
    Jiang, Chuanlu
    Cai, Jinquan
    WORLD NEUROSURGERY, 2019, 130 : E236 - E243
  • [27] Feasibility of proton beam therapy as a rescue therapy in heavily pre-treated retinoblastoma eyes
    Biewald, E.
    Kiefer, T.
    Dirk, G.
    Sabrina, S.
    Sophia, G.
    Joerg, W.
    Beate, T.
    Petra, K.
    Stefan, S.
    Saskia, T.
    Nikolaos, B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (05): : 1067 - 1067
  • [28] Feasibility of Proton Beam Therapy as a Rescue Therapy in Heavily Pre-Treated Retinoblastoma Eyes
    Biewald, Eva
    Kiefer, Tobias
    Geismar, Dirk
    Schlueter, Sabrina
    Manthey, Anke
    Westekemper, Henrike
    Wulff, Joerg
    Timmermann, Beate
    Ketteler, Petra
    Schoenberger, Stefan
    Metz, Klaus A.
    Ting, Saskia
    Goricke, Sophia
    Bechrakis, Nikolaos E.
    Bornfeld, Norbert
    CANCERS, 2021, 13 (08)
  • [29] A Phase II Study of Cisplatin and Temozolomide in Heavily Pre-treated Patients with Temozolomide-refractory High-grade Malignant Glioma
    Zustovich, Fable
    Lombardi, Giuseppe
    Della Puppa, Alessandro
    Rotilio, Antonino
    Scienza, Renato
    Pastorelli, Davide
    ANTICANCER RESEARCH, 2009, 29 (10) : 4275 - 4279
  • [30] Pembrolizumab in combination with bevacizumab and oral cyclophosphamide in heavily pre-treated platinum-resistant ovarian cancer
    Andrikopoulou, Angeliki
    Liontos, Michalis
    Skafida, Efthymia
    Koutsoukos, Konstantinos
    Apostolidou, Kleoniki
    Kaparelou, Maria
    Rouvalis, Angeliki
    Bletsa, Garyfallia
    Dimopoulos, Meletios-Athanasios
    Zagouri, Flora
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (04) : 571 - 576
12345